Early weight loss during tirzepatide treatment was predominantly fat mass, with a BIA-derived FFM fraction numerically close to the commonly cited one-fourth.
Enes Zafer, D. Çekiç, A. Genç et al.· Journal of Clinical Medicine· 0 citations
Aim/Objective: Dexmedetomidine (DEX), a highly selective α2-adrenoceptor agonist, has sedative, analgesic, anxiolytic, and immunomodulatory properties that may provide benefits in critically ill patients with COVID-19. This study aimed to evaluate the effect of DEX on clinical outcomes in patients with severe COVID-19...
Kubilay Işsever, A. Genç, A. C. Genç et al.· Cukurova Anestezi ve Cerrahi...· 0 citations
The role of FIB-4 as a simple, cost-effective tool for integrated cardio-hepato-renal risk stratification is supported, and impaired kidney function in patients with MASLD beyond established cardiometabolic risk factors is independently associated with impaired kidney function in patients with MASLD.
H. Sumbul, A. Kırık, S. Yaylacı et al.· Hepatology International· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.